New Zealand’s community pharmacies have quietly taken on a significant new role. Since 2 June, they can assess patients and supply funded medicines for a range of common conditions, from urinary tract infections to emergency contraception, without a GP prescription. Over 90% of pharmacies have signed up. The government calls it better access. The honest description is demand displacement from one strained sector to another.
The scheme is backed by a $5 million annual fund, and that number tells you everything about how seriously the structural problem is being addressed.
A sensible policy with inadequate backing
The logic is hard to argue with. Pharmacists are clinically qualified, geographically accessible, and open longer hours than most GP practices. The UK, Canada, and Australia have run minor ailments schemes for years. Health Minister Simeon Brown made the cost case plainly: a family with three children could pay up to $100 over the counter for head lice treatment, versus $5 through the pharmacy scheme.
Associate Health Minister David Seymour pointed to the access gap in rural and high-needs communities, where timely GP appointments remain difficult to secure. That gap is real. Health NZ data from mid-2025 showed only about half of general practices were open to new enrolments, with the proportion accepting patients improving only marginally, from 70.3% to 71.3% between March and June 2025.
But the $5 million was not new Budget 2026 money. It was secured during a prior National Annual Agreement Review. For context, the government committed $180 million in new general practice funding in 2025/26, including a 6.43% capitation increase. The pharmacy expansion got less than 3% of that figure. The ambition is nationwide. The funding is a rounding error.
You cannot route patients to a sector that is also in crisis
Here is where the policy runs into its own contradiction. The pharmacy workforce is under severe pressure. At least 20 community pharmacies have closed in the last three years. There is an estimated shortfall of roughly 1,000 full-time equivalent pharmacists. Around 92% of rural community pharmacies have experienced staff shortages, and approximately 74% of all community pharmacies report staffing difficulties.
Pharmacy Guild president Keshree Naidoo-Rauf supports the scheme, framing pharmacies as the ideal access point for patients who would otherwise end up in the emergency department. But the same article notes the sector’s workforce crisis, a tension the Guild has not publicly reconciled.
Pharmaceutical Society of NZ president Michael Hammond was more direct. He welcomed the policy in April, noting that “too many people are waiting too long to see a GP”. But by May, he characterised Budget 2026 as “fundamentally a stabilisation budget for health rather than a transformational one”, saying the expansion was “just one step in the right direction” and expressing disappointment at the absence of a structural shift that would “really fully utilise pharmacy within our health system”.
GPs are not just defending their turf
General Practice Owners Association chair Angus Chambers offered a critique that deserves more attention than it has received. He argues that “a better solution to improve access to healthcare would be funding general practice appropriately”, while acknowledging pharmacy also needs proper funding. His prediction: the scheme will likely increase referrals to telehealth consultations rather than resolve the underlying access problem.
This is not protectionism. It is a sector leader pointing out that moving demand sideways does not create capacity.
What this means if you employ people
For business owners, primary care access is a productivity issue. When staff cannot get enrolled with a GP, or face multi-day waits for an appointment, the consequences are longer absences, delayed treatment, avoidable ED visits, and presenteeism. The pharmacy scheme addresses exactly the kind of conditions that keep people off work or distracted at their desk: UTIs, conjunctivitis, head lice, pain management.
That makes it genuinely useful in the short term. But it does not fix the underlying problem. The government deserves credit for expanding pharmacists’ scope of practice faster than previous administrations managed. The UK model works. The principle is sound. What is missing is the investment to match the policy’s own logic. Five million dollars a year, drawn from existing allocations, does not build workforce capacity in a sector short 1,000 pharmacists and closing 20 shops in three years.
The question for the next budget is whether the government treats this as a pilot or a permanent workaround. If pharmacies are now a core part of primary care delivery, they need to be funded like it.
Sources
- Pharmac: Decision to extend Pharmacy Services (2026-05-20)
- NZ Herald: Pharmacies can now treat common conditions without GP visits
- 1News: Expanded prescribing role for pharmacists welcomed (2026-04-15)
- Beehive: Expanded role for community pharmacists
- Pharmacy Today: Community pharmacists enthusiastic about minor-ailments scheme (2026-06-17)
- Pharmacy Today: PSNZ welcomes extended pharmacy services (2026-04-16)
- Pharmacy Today: Structural shift to fully utilise pharmacy still on wish list (2026-05-28)
- Point of Order: When the doc is too busy to help (2026-05-06)